Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

33.00p
   
  • Change Today:
    -0.70p
  • 52 Week High: 71.80
  • 52 Week Low: 32.90
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,099,528
  • Market Cap: £178.33m
  • RiskGrade: 119
  • Beta: 0.00

Balance Sheet

  £ (Millions) £ (Millions)
Balance Sheet 31-Dec-08 31-Dec-07
Non-Current Assets    
Property, Plant & Equipment 0.16 0.25
Intangible Assets 39.95 39.16
Investment Properties n/a n/a
Investments n/a n/a
Other Financial Assets n/a n/a
Other Non-Current Assets 0.07 n/a
  40.18 39.41
Current Assets    
Inventories 2.27 1.88
Trade & Other Receivables 6.38 4.44
Current Investments - Listed n/a n/a
Current Investments - Deposits n/a n/a
Current Investments - Unlisted n/a n/a
Cash at Bank & in Hand n/a 0.67
Cash on Short Term Deposit n/a n/a
Other Current Assets n/a n/a
  8.65 6.99
     
Other Assets n/a n/a
Total Assets 48.83 46.41
     
Current Liabilities    
Trade & Other Payables 5.85 4.87
Borrowings 2.30 1.72
Finance Lease Obligations n/a n/a
Other Current Liabilities 3.00 3.18
  11.14 9.77
     
Net Current Assets en/a en/a
     
Non-Current Liabilities    
Borrowings 27.78 29.02
Finance Lease Obligations n/a n/a
Other Non-Current Liabilities 1.11 0.95
Provisions - Deferred Tax 0.03 n/a
Provisions - Other n/a n/a
  28.92 29.97
     
Other Liabilities n/a n/a
Total Liabilities 40.07 39.74
     
Net Assets 8.77 6.67
     
Share Capital 1.62 1.62
Share Premium Account 11.27 11.27
Other Reserves (1.23) (0.82)
Retained Earnings (2.90) (5.41)
  8.76 6.67
     
Minority Interests/Other Equity n/a n/a
Total Equity 8.77 6.67
  £ (Millions) £ (Millions)
Notes to Balance Sheet 31-Dec-08 31-Dec-07
Shareholders Funds - Equity en/a en/a
Shareholders Funds - Non Equity en/a en/a
  en/a en/a
     
Borrowing Analysis    
Borrowings Under 1 year n/a n/a
Due 1 - 2 years n/a n/a
Due 2 - 5 years n/a n/a
Due After 5 years n/a n/a
Due 1 - 5 years Unanalysed n/a n/a
Due After 1 year Unanalysed n/a n/a
Less: Borrowings in Other Creditors n/a n/a
Total Borrowings 30.07 30.74
     
Property, Plant & Equipment Analysis    
Property    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchanges & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Depreciation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Net Book Value n/a n/a
     
Other Fixed Assets    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Other Fixed Assets Deprecation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
At End of Year n/a n/a
     
Other Fixed Assets Net Book Value n/a n/a
     
Total Property, Plant & Equipment Net Book Value n/a n/a

Key

* GAAP

a. Total fixed assets

b. Debtors due within and after one year

c. Includes trade and other payables

d. Includes non-current assets

e. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page